Wilmer Cutler Pickering Hale and Dorr advised Ratio Therapeutics Inc in the transaction. Ratio Therapeutics Inc, a pharmaceutical company, announced its exclusive worldwide license and collaboration...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Orna Therapeutics on the transaction. Orna Therapeutics, a biotechnology company, announced its acquisition of ReNAgade Therapeutics, a pioneer in...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised MKS Instruments, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers. MKS...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented TechTarget, Inc. in the transaction, and Clifford Chance represented Informa PLC. TechTarget, Inc. (NASDAQ: TTGT) and Informa PLC (LSE:...
You must be a Standard 1 Year member to access this content.
